查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1750654

美國心血管健康補充劑市場：市場規模、佔有率、趨勢分析（按成分、形式、類型、分銷管道和地區）、細分市場預測（2025-2030 年）

U.S. Cardiovascular Health Supplements Market Size, Share & Trends Analysis Report By Ingredient, By Form, By, Type, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

美國心血管健康補充品市場的成長與趨勢：

根據Grand View Research, Inc.的最新報告，美國心血管健康補充品市場規模預計到2030年將達到32.7億美元，預測期內的複合年成長率為7.61%。

這一強勁成長主要源於心血管疾病患病率的上升、健康意識的增強以及人口老化帶來的預防性醫療保健需求的增加。由於心臟相關疾病仍然是美國最大的死亡原因，消費者正在轉向天然的非處方箋解決方案來管理和降低相關風險。

Omega-3脂肪酸、輔酶Q10、鎂和植物固醇等關鍵成分因其在支持心臟健康方面的功效已被證實，繼續佔據市場主導地位。此外，軟膠囊、膠囊和緩釋片等補充劑輸送系統的進步正在提高生物利用度和消費者依從性。向潔淨標示、植物來源和臨床支持配方的轉變也影響著消費者的購買決策，尤其是在注重健康的老年人群中，他們尋求長期健康解決方案。這將在預測期內推動美國對心血管健康補充劑的需求。

新冠疫情顯著提升了美國市場對心血管健康補充劑的需求，這得益於人們健康意識的增強、對免疫力和慢性病預防的日益關注，以及人們更加注重積極健康的生活方式。消費者對自身基礎健康（包括心臟健康）的關注度不斷提升，導致對含有Omega-3、輔酶 Q10 和其他有益心臟成分的補充劑的需求激增。

然而，儘管需求不斷成長，美國心血管健康補充劑產業仍面臨許多挑戰，包括有限的臨床檢驗、有關健康聲明的限制性法規以及各品牌產品品質缺乏一致性。這些因素加劇了消費者的疑慮，並降低了醫療保健專業人員的採用率。此外，高昂的產品成本和缺乏保險覆蓋進一步限制了產品的可及性，共同阻礙了市場的成長。

美國心血管健康補充品市場：分析概述

  • 2024年，歐米伽脂肪酸佔據了最大的市場佔有率，達到27.36%，這得益於其在降低高膽固醇和高血壓等心血管風險因素方面眾所周知的作用。然而，預計在預測期內，草藥和植物藥的複合年成長率將最快。
  • 預計天然補充劑領域將在 2024 年佔據市場主導地位，並在預測期內以最快的複合年成長率成長，這歸因於消費者對潔淨標示、植物來源、最低限度加工且具有公認安全性和長期健康益處的產品的偏好日益成長。
  • 軟膠囊憑藉其便捷的劑型和消費者對易於服用的補充劑的偏好，在2024年佔據了最大的市場佔有率。然而，預計在預測期內，膠囊的複合年成長率將達到最高。
  • 線下分銷管道部分將在 2024 年佔據市場主導地位，佔據最大的收益佔有率。然而，預計在預測期內，線上部分將以最快的複合年成長率成長。

目錄

第1章 分析方法與範圍

第2章執行摘要

第3章 市場促進因素、趨勢與範圍

  • 市場聯動展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制分析
  • 美國心血管健康補充品市場：分析工具
    • 產業分析：波特五力分析
    • PESTEL分析
    • COVID-19影響分析

第4章美國心血管健康補充劑市場：按成分的估計和趨勢分析

  • 特定成分的儀表板
  • 美國心血管保健品市場成分波動
  • 美國心血管健康補充品市場規模及成分趨勢分析（2018-2030）
  • 維生素和礦物質
    • 維生素和礦物質市場（2018-2030）
  • 草藥和植物
    • 草藥和植物市場（2018-2030）
  • 歐米茄脂肪酸
    • 歐米茄脂肪酸市場（2018-2030）
  • Coenzyme Q10（CoQ10）
    • Coenzyme Q10（CoQ10）市場（2018-2030）
  • 其他
    • 其他市場（2018-2030）

第5章美國心血管健康補充劑市場：按類型估計和趨勢分析

  • 按類型分類的儀表板
  • 美國心血管保健品市場各類型波動
  • 美國心血管健康補充品市場規模及趨勢分析（2018-2030）
  • 天然補充品
    • 天然補充品市場（2018-2030）
  • 合成補充劑
    • 合成補充劑市場（2018-2030）

第6章美國心血管健康補充劑市場：按形式進行的估計和趨勢分析

  • 按形狀分類的儀表板
  • 美國心血管保健品市場各形態的波動
  • 美國心血管健康補充品市場規模及趨勢分析（2018-2030）
  • 液體
    • 流動性市場（2018-2030）
  • 錠劑
    • 錠劑市場（2018-2030）
  • 膠囊
    • 膠囊市場（2018-2030）
  • 軟膠囊
    • 軟膠囊市場（2018-2030）
  • 粉末
    • 粉末市場（2018-2030）
  • 其他
    • 其他市場（2018-2030）

第7章美國心血管健康補充品市場：通路評估與趨勢分析

  • 按分銷管道分類的儀表板
  • 美國心血管保健品市場通路的波動
  • 美國心血管健康補充品市場規模及通路趨勢分析（2018-2030）
  • 離線
    • 線下市場（2018-2030）
  • 線上
    • 線上市場（2018-2030）

第8章 競爭態勢

  • 公司分類
  • 戰略地圖
  • 公司簡介/上市公司
    • NOW Foods
    • Bright Lifecare Private Ltd（Truebasics.com）
    • Natural Organics, Inc.
    • DaVinci Laboratories of Vermont
    • Nordic Naturals
    • Thorne.
    • Nestle Health Science（Pure Encapsulations, LLC.）
    • Amway Corp.
    • InVite Health
    • GNC Holdings, LLC
Product Code: GVR-4-68040-574-9

U.S. Cardiovascular Health Supplements Market Growth & Trends:

The U.S. cardiovascular health supplements market size is anticipated to reach USD 3.27 billion by 2030 and is projected to grow at a CAGR of 7.61% during the forecast period, according to a new report by Grand View Research, Inc. This robust growth is largely attributed to the increasing incidence of cardiovascular diseases, rising health consciousness, and the aging population's growing demand for preventive healthcare. As heart-related conditions remain a leading cause of mortality in the U.S., consumers are increasingly seeking non-prescription, natural solutions to manage and reduce associated risks.

Key ingredients such as omega-3 fatty acids, CoQ10, magnesium, and plant sterols continue to dominate the market due to their proven benefits in supporting heart health. In addition, advancements in supplement delivery systems-such as softgels, capsules, and extended-release tablets-are enhancing bioavailability and consumer adherence. The shift toward clean-label, plant-based, and clinically supported formulations is also influencing purchasing decisions, especially among health-conscious and senior demographics seeking long-term wellness solutions. Thereby propelling the demand for cardiovascular health supplements in the U.S. over the forecast period.

The COVID-19 pandemic substantially boosted the demand for cardiovascular health supplements in the U.S. market, driven by heightened health awareness, increased focus on immunity and chronic disease prevention, and a shift toward proactive wellness. Consumers became more conscious of underlying health conditions, including heart health, leading to a surge in demand for supplements containing omega-3s, CoQ10, and other heart-supportive ingredients.

However, despite rising demand, the U.S. cardiovascular health supplements industry faces challenges such as limited clinical validation, regulatory restrictions on health claims, and inconsistent product quality across brands. These factors contribute to consumer skepticism and reduce adoption among healthcare professionals. In addition, high product costs and lack of insurance coverage further limit accessibility, collectively hampering the growth of the market.

U.S. Cardiovascular Health Supplements Market Report Highlights:

  • The omega fatty acids held the largest market share of 27.36% in 2024. This is attributed to their well-documented benefits in reducing cardiovascular risk factors such as high cholesterol and blood pressure. However, herbs & botanicals are anticipated to grow at the fastest CAGR over the forecast period.
  • The natural supplements segment dominated the market in 2024 and is anticipated to grow at the fastest CAGR over the forecast period. This is driven by increasing consumer preference for clean-label, plant-based, and minimally processed products with perceived safety and long-term health benefits.
  • The softgels held the largest market share in 2024. This is driven by their convenient dosage form and consumer preference for easy-to-consume supplements. However, capsules are anticipated to grow at the fastest CAGR over the forecast period.
  • The offline distribution channel segment dominated the market with the largest revenue share in 2024. However, the online segment is expected to grow at the fastest CAGR over the forecast period.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
    • 1.2.1. Ingredient Segment
    • 1.2.2. Type Segment
    • 1.2.3. Form Segment
    • 1.2.4. Distribution Channel Segment
  • 1.3. Information analysis
  • 1.4. Market formulation & data visualization
  • 1.5. Data validation & publishing
  • 1.6. Information Procurement
    • 1.6.1. Primary Research
  • 1.7. Information or Data Analysis
  • 1.8. Market Formulation & Validation
  • 1.9. Market Model
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of cardiovascular diseases
      • 3.2.1.2. Aging population
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High competition and market saturation
  • 3.3. U.S. Cardiovascular Health Supplements Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
    • 3.3.2. PESTEL Analysis
    • 3.3.3. COVID-19 Impact Analysis

Chapter 4. U.S. Cardiovascular Health Supplement Market: Ingredient Estimates & Trend Analysis

  • 4.1. Ingredient Segment Dashboard
  • 4.2. U.S. Cardiovascular Health Supplement Market Ingredient Movement Analysis
  • 4.3. U.S. Cardiovascular Health Supplement Market Size & Trend Analysis, by Ingredient, 2018 to 2030 (USD Million)
  • 4.4. Vitamins & Minerals
    • 4.4.1. Vitamins & Minerals Market, 2018 - 2030 (USD Million)
  • 4.5. Herbs & Botanicals
    • 4.5.1. Herbs & Botanicals Market, 2018 - 2030 (USD Million)
  • 4.6. Omega Fatty Acids
    • 4.6.1. Omega Fatty Acids Market, 2018 - 2030 (USD Million)
  • 4.7. Coenzyme Q10 (CoQ10)
    • 4.7.1. Coenzyme Q10 (CoQ10) Market, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. U.S. Cardiovascular Health Supplement Market: Type Estimates & Trend Analysis

  • 5.1. Type Segment Dashboard
  • 5.2. U.S. Cardiovascular Health Supplement Market Type Movement Analysis
  • 5.3. U.S. Cardiovascular Health Supplement Market Size & Trend Analysis, by Type, 2018 to 2030 (USD Million)
  • 5.4. Natural Supplements
    • 5.4.1. Natural Supplements Market, 2018 - 2030 (USD Million)
  • 5.5. Synthetic Supplements
    • 5.5.1. Synthetic Supplements Market, 2018 - 2030 (USD Million)

Chapter 6. U.S. Cardiovascular Health Supplements Market: Form Estimates & Trend Analysis

  • 6.1. Form Segment Dashboard
  • 6.2. U.S. Cardiovascular Health Supplements Market Form Movement Analysis
  • 6.3. U.S. Cardiovascular Health Supplements Market Size & Trend Analysis, by Form, 2018 to 2030 (USD Million)
  • 6.4. Liquid
    • 6.4.1. Liquid Market, 2018 - 2030 (USD Million)
  • 6.5. Tablet
    • 6.5.1. Tablet Market, 2018 - 2030 (USD Million)
  • 6.6. Capsules
    • 6.6.1. Capsules Market, 2018 - 2030 (USD Million)
  • 6.7. Softgels
    • 6.7.1. Softgels Market, 2018 - 2030 (USD Million)
  • 6.8. Powder
    • 6.8.1. Powder Market, 2018 - 2030 (USD Million)
  • 6.9. Others
    • 6.9.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. U.S. Cardiovascular Health Supplements Market: Distribution Channel Estimates & Trend Analysis

  • 7.1. Distribution Channel Segment Dashboard
  • 7.2. U.S. Cardiovascular Health Supplements Market Distribution Channel Movement Analysis
  • 7.3. U.S. Cardiovascular Health Supplements Market Size & Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 7.4. Offline
    • 7.4.1. Offline Market, 2018 - 2030 (USD Million)
  • 7.5. Online
    • 7.5.1. Online Market, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Categorization
  • 8.2. Strategy Mapping
  • 8.3. Company Profiles/Listing
    • 8.3.1. NOW Foods
      • 8.3.1.1. Overview
      • 8.3.1.2. Financial Performance
      • 8.3.1.3. Product Benchmarking
      • 8.3.1.4. Strategic Initiatives
    • 8.3.2. Bright Lifecare Private Ltd (Truebasics.com)
      • 8.3.2.1. Overview
      • 8.3.2.2. Financial Performance
      • 8.3.2.3. Product Benchmarking
      • 8.3.2.4. Strategic Initiatives
    • 8.3.3. Natural Organics, Inc.
      • 8.3.3.1. Overview
      • 8.3.3.2. Financial Performance
      • 8.3.3.3. Product Benchmarking
      • 8.3.3.4. Strategic Initiatives
    • 8.3.4. DaVinci Laboratories of Vermont
      • 8.3.4.1. Overview
      • 8.3.4.2. Financial Performance
      • 8.3.4.3. Product Benchmarking
      • 8.3.4.4. Strategic Initiatives
    • 8.3.5. Nordic Naturals
      • 8.3.5.1. Overview
      • 8.3.5.2. Financial Performance
      • 8.3.5.3. Product Benchmarking
      • 8.3.5.4. Strategic Initiatives
    • 8.3.6. Thorne.
      • 8.3.6.1. Overview
      • 8.3.6.2. Financial Performance
      • 8.3.6.3. Product Benchmarking
      • 8.3.6.4. Strategic Initiatives
    • 8.3.7. Nestle Health Science (Pure Encapsulations, LLC.)
      • 8.3.7.1. Overview
      • 8.3.7.2. Financial Performance
      • 8.3.7.3. Product Benchmarking
      • 8.3.7.4. Strategic Initiatives
    • 8.3.8. Amway Corp.
      • 8.3.8.1. Overview
      • 8.3.8.2. Financial Performance
      • 8.3.8.3. Product Benchmarking
      • 8.3.8.4. Strategic Initiatives
    • 8.3.9. InVite Health
      • 8.3.9.1. Overview
      • 8.3.9.2. Financial Performance
      • 8.3.9.3. Product Benchmarking
      • 8.3.9.4. Strategic Initiatives
    • 8.3.10. GNC Holdings, LLC
      • 8.3.10.1. Overview
      • 8.3.10.2. Financial Performance
      • 8.3.10.3. Product Benchmarking
      • 8.3.10.4. Strategic Initiatives

List of Tables

  • Table 1. U.S. cardiovascular health supplements market estimates & forecasts
  • Table 2. U.S. cardiovascular health supplements market estimates & forecasts, by ingredient, 2018 - 2030 (USD Million)
  • Table 3. U.S. cardiovascular health supplements market estimates & forecasts, by type, 2018 - 2030 (USD Million)
  • Table 4. U.S. cardiovascular health supplements market estimates & forecasts, by form, 2018 - 2030 (USD Million)
  • Table 5. U.S. cardiovascular health supplements market estimates & forecasts, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market snapshot
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Market trends & outlook
  • Fig. 7 Market segmentation & scope
  • Fig. 8 Market driver relevance analysis (Current & future impact)
  • Fig. 9 Market restraint relevance analysis (Current & future impact)
  • Fig. 10 PESTLE Analysis
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 Strategy framework
  • Fig. 13 Participant categorization
  • Fig. 14 U.S. cardiovascular health supplements market: Ingredient outlook key takeaways
  • Fig. 15 U.S. cardiovascular health supplements market: Ingredient movement analysis
  • Fig. 16 Vitamins & minerals market, 2018 - 2030 (USD Million)
  • Fig. 17 Herbs & botanicals market, 2018 - 2030 (USD Million)
  • Fig. 18 Omega fatty acids market, 2018 - 2030 (USD Million)
  • Fig. 19 Coenzyme Q10 (CoQ10) market, 2018 - 2030 (USD Million)
  • Fig. 20 Others market, 2018 - 2030 (USD Million)
  • Fig. 21 U.S. cardiovascular health supplements market: Type outlook key takeaways
  • Fig. 22 U.S. cardiovascular health supplements market: Type movement analysis
  • Fig. 23 Natural supplements market, 2018 - 2030 (USD Million)
  • Fig. 24 Synthetic supplements market, 2018 - 2030 (USD Million)
  • Fig. 25 U.S. cardiovascular health supplements market: Form outlook key takeaways
  • Fig. 26 U.S. cardiovascular health supplements market: Form movement analysis
  • Fig. 27 Liquid market, 2018 - 2030 (USD Million)
  • Fig. 28 Capsules market, 2018 - 2030 (USD Million)
  • Fig. 29 Tablets market, 2018 - 2030 (USD Million)
  • Fig. 30 Softgels market, 2018 - 2030 (USD Million)
  • Fig. 31 Powder market, 2018 - 2030 (USD Million)
  • Fig. 32 Others market, 2018 - 2030 (USD Million)
  • Fig. 33 U.S. cardiovascular health supplements market: End use outlook key takeaways
  • Fig. 34 U.S. cardiovascular health supplements market: End use movement analysis
  • Fig. 35 Offline market, 2018 - 2030 (USD Million)
  • Fig. 36 Online market, 2018 - 2030 (USD Million)
  • Fig. 37 U.S. cardiovascular health supplements market, 2018 - 2030 (USD Million)
  • Fig. 38 Key companies profiled